Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Activists urge Biden to push for intellectual property waiver for COVID-19 vaccines

Stock MarketsNov 22, 2021 10:06AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO:U.S. President Joe Biden speaks about the state of vaccinations during a coronavirus disease (COVID-19) response event in the East Room at the White House in Washington, U.S., March 18, 2021. REUTERS/Carlos Barria

By Andrea Shalal

WASHINGTON (Reuters) -Fifteen medical and human rights groups are urging U.S. President Joe Biden to get personally engaged in a long-running fight to enact an intellectual property waiver for COVID-19 vaccines at the World Trade Organization, calling his leadership "a moral necessity."

Amnesty International, Doctors without Borders, Human Rights Watch, Public Citizen and 11 other groups told Biden in a letter that an emergency waiver was urgently needed to combat the pandemic, noting that fewer than 7% of people in low-income countries had received a first COVID-19 shot and vaccines remained scarce.

More than 5.4 million people have died of COVID-19 around the world https://graphics.reuters.com/world-coronavirus-tracker-and-maps since the first cases were identified in China in December 2019.

Biden reversed the previous U.S. position to endorse a waiver in May https://www.reuters.com/business/healthcare-pharmaceuticals/biden-says-plans-back-wto-waiver-vaccines-2021-05-05, a move that caught some allies by surprise, but there has been little progress since then. The European Union, Britain and Switzerland remain opposed, arguing that issuing such waivers would undercut years of investment and research.

The White House last month called on all WTO members to support a temporary waiver https://www.reuters.com/world/us/white-house-wto-members-must-support-intellectual-property-waiver-covid-vaccines-2021-10-21 and WTO Director-General Ngozi Okonjo-Iweala is pushing for a deal at a WTO ministerial conference in Geneva from Nov. 30 to Dec. 3.

In their letter, a copy of which was viewed by Reuters, the rights groups said they were "very disappointed" that the Biden administration had not done more to secure an agreement on a waiver text since Biden's strong statement in May.

"U.S. passivity has empowered close U.S. allies - the European Union, on behalf of Germany, plus Switzerland and the United Kingdom - to block progress even as millions die or become seriously ill waiting for effective vaccines and treatments," the groups wrote.

They urged Biden to step up his personal engagement and lead the world in reaching a meaningful agreement on the long-standing issue. Doing so would help end the pandemic and restore U.S. standing around the world, they said.

Activists say they have gathered 3 million signatures on petitions urging Biden to step up U.S. efforts and will deliver them on Tuesday.

The White House had no immediate comment on the letter, which was dated Friday.

Ending the ministerial meeting without a waiver agreement would be entirely unacceptable," the groups said. They said drugmakers were using their intellectual property rights to segment global markets instead of maximizing the scale of generic production.

U.S officials oppose a separate effort to issue a "declaration on trade and health" led by David Walker, the New Zealand envoy to the WTO, according to a Geneva trade delegate and a second source briefed on the matter.

In their letter, the groups said the declaration, if passed without a meaningful intellectual property rights waiver, would "further undermine the WTO's relevance and legitimacy."

Activists urge Biden to push for intellectual property waiver for COVID-19 vaccines
 

Related Articles

Weibo shares close down 7.2% in Hong Kong debut
Weibo shares close down 7.2% in Hong Kong debut By Reuters - Dec 08, 2021

By Scott Murdoch HONG KONG (Reuters) -Chinese social media giant Weibo (NASDAQ:WB) Corp's shares closed 7.2% below their issue price in Hong Kong on Wednesday, as it became the...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (3)
El Broker
El Broker Nov 22, 2021 8:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
think about it 7% and yet no one is worried about it ...life goes on ..and in countries ruled by elitist socialists and pharmaceutical companies 80% have shot and everyone is in fear and almost lock down
Ogo Pogo
Ogo Pogo Nov 22, 2021 3:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Waiving IP is stealing. It will set a dangerous precedent and will wipe out lots of small biotechs (btw lots of them are on the brink already, go check the sector) that spent years researching and actually own the IP (e.g. ABUS). Others are waiting for FDA bureaucrats to approve their C-19 meds. Nobody seems to be in a hurry to find some treatment. Meanwhile the FED is busy pumping money into the big tech bubble. Perhaps the WTO lady should go ask FAANG for a vaccine or an IP waive.
DJ Ryte
DJ Ryte Nov 22, 2021 1:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Brandon waives goodbye to undercutting big Pharma buddies.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email